TeamViewer (TMV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 delivered strong results with 9% constant currency revenue growth year-over-year and a robust adjusted EBITDA margin of 41%.
Enterprise segment achieved double-digit revenue growth (up to 21% year-over-year in constant currency), with NRR increasing to 116%.
Americas region saw robust growth and new high-profile customers, while all regions contributed to overall performance.
Maintained high customer trust and product usage despite a cybersecurity incident, which was contained and had no impact on customer data or product environment.
Recognized with industry awards and expanded partnerships, including Microsoft Partner of the Year and new strategic alliances.
Financial highlights
Q2 2024 revenue reached €164.1 million, up 9% year-over-year in constant currency, with adjusted EBITDA of €67.5 million and a margin of 41%.
Levered free cash flow increased 29% year-over-year to €60.8 million, with cash conversion at 90%.
Net income was €26.5 million, down 22% year-over-year due to higher taxes after a prior-year one-off benefit.
ARR based on billings rose 7% to €667 million; total NRR was 102%.
Adjusted EPS up 8% year-over-year to €0.24, aided by share buybacks.
Outlook and guidance
Full-year 2024 revenue guidance reaffirmed at €660–685 million, implying 7–11% constant currency growth.
Adjusted EBITDA margin guidance maintained at at least 43%, with margin expected to rise in H2.
Billings growth in H2 expected to accelerate to 6–7% in Q3 and Q4, driven by enterprise deals.
Confident in delivering pre-tax levered free cash flow growth of ~12% for the year.
Margin improvement in H2 2024 expected from cost savings and growth initiatives.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025